Minimal Residual Disease Market Overview
Minimal Residual Disease (MRD) refers to the small number of cancer cells that remain in the body after treatment and may lead to relapse. Detecting MRD plays a crucial role in determining the effectiveness of therapies, especially in hematological malignancies like leukemia and lymphoma. The MRD market is rapidly growing due to increasing prevalence of cancer, advancements in diagnostic technologies, and rising focus on personalized medicine.